Roche Holding AG (ROG), the world’s largest maker of cancer drugs, started research on vaccines for AIDS, tuberculosis and Hepatitis C in early April, Der Sonntag reported, citing spokeswoman Claudia Schmitt.
The research was begun in cooperation with the French Agency for Research on AIDS and viral hepatitis, the French National Research Institute and the Baylor Research Institute in Texas, Schmitt told the newspaper. Schmitt declined to comment on market potential or on how much Roche invested into the development of the vaccines.
To contact the reporter on this story: Corinne Gretler in Zurich at email@example.com
To contact the editor responsible for this story: Andrew Rummer at firstname.lastname@example.org